Cencora, Inc. (FRA:ABG)

Market Cap	59.62B +26.5%
Revenue (ttm)	277.46B +7.4%
Net Income	1.38B +16.4%
EPS	7.10 +18.6%
Shares Out	n/a
PE Ratio	43.07
Forward PE	20.07
Dividend	1.98 (0.66%)
Ex-Dividend Date	Feb 13, 2026

Volume	n/a
Average Volume	1
Open	302.65
Previous Close	302.45
Day's Range	302.65 - 302.65
52-Week Range	230.20 - 327.10
Beta	n/a
RSI	55.12
Earnings Date	Feb 4, 2026

About Cencora

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company’s U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, ...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1871
• Employees: 49,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: ABG

Financial Performance

In fiscal year 2025, Cencora's revenue was $321.33 billion, an increase of 9.31% compared to the previous year's $293.96 billion. Earnings were $1.55 billion, an increase of 2.99%.

Financial numbers in USD